Evidence-based opinion at the intersection of science, policy, and society
Four regulators found GR2E Golden Rice as safe as conventional rice between 2017 and 2021, and a 24-province pilot then grew and distributed it. What stopped it in 2024 was a Writ of Kalikasan sought by advocacy organisations, not any new scientific finding. The concession, the evidence, and the pending Supreme Court case.
Recurring misrepresentations in mainstream plant-biotech reporting are not isolated errors — they are a documented structural failure that propagates from press releases through wire syndication into binding regulation. Five error modes, the propagation pipeline, and a positive standard.
Structural critique of externally-funded agricultural research programs in Sub-Saharan Africa: five mechanisms by which donor dependency actively harms plant science, the endogenous building blocks already in place, and a five-pillar reform agenda for the post-USAID era.
Critical evaluation of the CO₂ fertilization effect: the chamber-to-field gap, C3/C4 asymmetry, nutrient dilution, the industry-origin history of the optimist narrative, and the quantifiable policy cost of carrying it into climate-economic models.
Some regulatory differences between transgenic and gene-edited crops have scientific grounding. The current global patchwork does not. An argued case for risk-proportionate, product-based governance of agricultural innovation.
In preparation. Subscribe below to be told when each one is published.
One evidence-based opinion article per week, delivered to your inbox. No spam, no fluff.
Your address is used only to send new articles. No tracking and no third parties; reply to any issue to unsubscribe.